RNASE9 antibody
Principal name
RNASE9 antibody
Alternative names for RNASE9 antibody
Ribonuclease-like protein 9
Ncbi ID
NP_001001673, ADR83498.1, NM_001110358, NM_001110359, NM_001110360, NM_001110361, NP_001103826, NP_001103827, NP_001103830, NP_001001673.2, NP_898853.2, NM_183032, NM_001001673, NM_001110356, NM_001110357
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of RNASE9 antibody
- Kit Component:
- - KN314873G1, Rnase9 gRNA vector 1 in pCas-Guide vector
- KN314873G2, Rnase9 gRNA vector 2 in pCas-Guide vector
- KN314873D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Cho,S., (2005) Genomics 85 (2), 208-220
Human Placenta; WB Suggested Anti-RNASE9 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Placenta; RNASE9 antibody - N-terminal region (ARP48114_P050) in Human Placenta cells using Western Blot
WB Suggested Anti-RNASE9 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: Human Placenta
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP760881 | RNASE9 (full length, N-term HIS tag, transcript variant 7) |
||||
| Purified recombinant protein of Human ribonuclease, RNase A family, 9 (non-active) (RNASE9), transcript variant 7, full length, with N-terminal HIS tag, expressed in E. coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760882 | RNASE9 (full length, N-term HIS tag, transcript variant 5) |
||||
| Purified recombinant protein of Human ribonuclease, RNase A family, 9 (non-active) (RNASE9), transcript variant 5, full length, with N-terminal HIS tag, expressed in E. coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760883 | RNASE9 (full length, N-term HIS tag, transcript variant 6) |
||||
| Purified recombinant protein of Human ribonuclease, RNase A family, 9 (non-active) (RNASE9), transcript variant 6, full length, with N-terminal HIS tag, expressed in E. coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760893 | RNASE9 (full length, N-term HIS tag, transcript variant 3) |
||||
| Purified recombinant protein of Human ribonuclease, RNase A family, 9 (non-active) (RNASE9), transcript variant 3, full length, with N-terminal HIS tag, expressed in E. coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY426322 | RNASE9 overexpression lysate |
|
 |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY426323 | RNASE9 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY426324 | RNASE9 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. | ||
| LY426325 | RNASE9 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216963L2V | Lenti ORF particles, Rnase9 (GFP-tagged) - Mouse ribonuclease, RNase A family, 9 (non-active) (Rnase9), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR216963L1V | Lenti ORF particles, Rnase9 (Myc-DDK-tagged) - Mouse ribonuclease, RNase A family, 9 (non-active) (Rnase9), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||